Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst (Nasdaq: HCAT) announced its participation in the upcoming Stephens Annual Investment Conference in Nashville. The company's leadership team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will take part in a fireside chat scheduled for Wednesday, November 20, 2024, at 1:00 pm CT.
Health Catalyst (Nasdaq: HCAT) ha annunciato la sua partecipazione alla prossima Conferenza Annuale sugli Investimenti di Stephens a Nashville. Il team dirigente dell'azienda, incluso il CEO Dan Burton, il CFO Jason Alger, il COO Dan LeSueur e il VP delle Relazioni con gli Investitori Jack Knight, parteciperà a una chiacchierata informale programmata per mercoledì 20 novembre 2024, alle 13:00 CT.
Health Catalyst (Nasdaq: HCAT) anunció su participación en la próxima Conferencia Anual de Inversiones de Stephens en Nashville. El equipo de liderazgo de la empresa, que incluye al CEO Dan Burton, al CFO Jason Alger, al COO Dan LeSueur y al VP de Relaciones con Inversores Jack Knight, participará en una conversación informal programada para el miércoles 20 de noviembre de 2024, a la 1:00 pm CT.
Health Catalyst (Nasdaq: HCAT)는 내슈빌에서 열리는 스티븐스 연례 투자 회의에 참여한다고 발표했습니다. 회사의 리더십 팀은 CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, 투자자 관계 부사장 Jack Knight가 포함되어 있으며, 2024년 11월 20일 수요일 오후 1시 CT에 예정된 화상 토론에 참여할 예정입니다.
Health Catalyst (Nasdaq: HCAT) a annoncé sa participation à la prochaine Conférence Annuelle d'Investissement de Stephens à Nashville. L'équipe dirigeante de l'entreprise, incluant le PDG Dan Burton, le directeur financier Jason Alger, le directeur des opérations Dan LeSueur et le VP des Relations Investisseurs Jack Knight, participera à une discussion informelle prévue pour le mercredi 20 novembre 2024, à 13h00 CT.
Health Catalyst (Nasdaq: HCAT) hat seine Teilnahme an der bevorstehenden Stephens Jahreskonferenz für Investitionen in Nashville bekannt gegeben. Das Führungsteam des Unternehmens, einschließlich CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur und VP für Investor Relations Jack Knight, wird an einem informellen Gespräch teilnehmen, das für Mittwoch, den 20. November 2024, um 13:00 Uhr CT geplant ist.
- None.
- None.
SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Stephens Annual Investment Conference, being held in Nashville, including a fireside chat on Wednesday, November 20, 2024, at 1:00 pm CT.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact:
Amanda Flanders
Senior Vice President, Marketing and Communications
media@healthcatalyst.com
FAQ
When is Health Catalyst (HCAT) participating in the Stephens Annual Investment Conference 2024?
Which Health Catalyst (HCAT) executives are attending the Stephens Conference 2024?
Where is the Stephens Annual Investment Conference 2024 being held for Health Catalyst (HCAT)?
